Annual D&A
$83.60 K
+$19.40 K+30.22%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual depreciation & amortization is $83.60 thousand, with the most recent change of +$19.40 thousand (+30.22%) on December 31, 2023.
- During the last 3 years, GANX annual D&A has risen by +$74.00 thousand (+770.83%).
- GANX annual D&A is now at all-time high.
Performance
GANX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$21.60 K
+$1000.00+4.85%
September 30, 2024
Summary
- As of February 12, 2025, GANX quarterly depreciation & amortization is $21.60 thousand, with the most recent change of +$1000.00 (+4.85%) on September 30, 2024.
- Over the past year, GANX quarterly D&A has dropped by -$2000.00 (-8.47%).
- GANX quarterly D&A is now -8.47% below its all-time high of $23.60 thousand, reached on December 31, 2023.
Performance
GANX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$86.30 K
+$1100.00+1.29%
September 30, 2024
Summary
- As of February 12, 2025, GANX TTM depreciation & amortization is $86.30 thousand, with the most recent change of +$1100.00 (+1.29%) on September 30, 2024.
- Over the past year, GANX TTM D&A has increased by +$2800.00 (+3.35%).
- GANX TTM D&A is now at all-time high.
Performance
GANX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
GANX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.2% | -8.5% | +3.4% |
| 3 y3 years | +770.8% | +272.4% | +456.8% |
| 5 y5 years | +10000.0% | +272.4% | +456.8% |
GANX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +439.4% | -8.5% | +272.4% | at high | +456.8% |
| 5 y | 5-year | at high | +3115.4% | -8.5% | +928.6% | at high | +4009.5% |
| alltime | all time | at high | >+9999.0% | -8.5% | +928.6% | at high | +4009.5% |
Gain Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $21.60 K(+4.9%) | $86.30 K(+1.3%) |
| Jun 2024 | - | $20.60 K(+0.5%) | $85.20 K(+0.5%) |
| Mar 2024 | - | $20.50 K(-13.1%) | $84.80 K(+1.6%) |
| Dec 2023 | $83.60 K(+30.2%) | $23.60 K(+15.1%) | $83.50 K(+7.1%) |
| Sep 2023 | - | $20.50 K(+1.5%) | $78.00 K(+3.6%) |
| Jun 2023 | - | $20.20 K(+5.2%) | $75.30 K(+0.3%) |
| Mar 2023 | - | $19.20 K(+6.1%) | $75.10 K(+17.2%) |
| Dec 2022 | $64.20 K(+314.2%) | $18.10 K(+1.7%) | $64.10 K(+23.7%) |
| Sep 2022 | - | $17.80 K(-11.0%) | $51.80 K(+36.0%) |
| Jun 2022 | - | $20.00 K(+143.9%) | $38.10 K(+87.7%) |
| Mar 2022 | - | $8200.00 | $20.30 K |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $15.50 K(+61.5%) | - | - |
| Dec 2021 | - | $5800.00(+41.5%) | $15.50 K(+24.0%) |
| Sep 2021 | - | $4100.00(+86.4%) | $12.50 K(+15.7%) |
| Jun 2021 | - | $2200.00(-35.3%) | $10.80 K(-0.9%) |
| Mar 2021 | - | $3400.00(+21.4%) | $10.90 K(+13.5%) |
| Dec 2020 | $9600.00(+269.2%) | - | - |
| Dec 2020 | - | $2800.00(+16.7%) | $9600.00(+41.2%) |
| Sep 2020 | - | $2400.00(+4.3%) | $6800.00(+54.5%) |
| Jun 2020 | - | $2300.00(+9.5%) | $4400.00(+109.5%) |
| Mar 2020 | - | $2100.00 | $2100.00 |
| Dec 2019 | $2600.00(+271.4%) | - | - |
| Dec 2018 | $700.00 | - | - |
FAQ
- What is Gain Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Gain Therapeutics?
- What is Gain Therapeutics annual D&A year-on-year change?
- What is Gain Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Gain Therapeutics?
- What is Gain Therapeutics quarterly D&A year-on-year change?
- What is Gain Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Gain Therapeutics?
- What is Gain Therapeutics TTM D&A year-on-year change?
What is Gain Therapeutics annual depreciation & amortization?
The current annual D&A of GANX is $83.60 K
What is the all time high annual D&A for Gain Therapeutics?
Gain Therapeutics all-time high annual depreciation & amortization is $83.60 K
What is Gain Therapeutics annual D&A year-on-year change?
Over the past year, GANX annual depreciation & amortization has changed by +$19.40 K (+30.22%)
What is Gain Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of GANX is $21.60 K
What is the all time high quarterly D&A for Gain Therapeutics?
Gain Therapeutics all-time high quarterly depreciation & amortization is $23.60 K
What is Gain Therapeutics quarterly D&A year-on-year change?
Over the past year, GANX quarterly depreciation & amortization has changed by -$2000.00 (-8.47%)
What is Gain Therapeutics TTM depreciation & amortization?
The current TTM D&A of GANX is $86.30 K
What is the all time high TTM D&A for Gain Therapeutics?
Gain Therapeutics all-time high TTM depreciation & amortization is $86.30 K
What is Gain Therapeutics TTM D&A year-on-year change?
Over the past year, GANX TTM depreciation & amortization has changed by +$2800.00 (+3.35%)